Completed PHASE1/PHASE2 INTERVENTIONAL NCT00118326

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Feasibility of Granulocyte-Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow From Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant

Sponsor: Fred Hutchinson Cancer Center

Conditions Kidney Cancer Leukemia Lymphoma Myelodysplastic Syndromes Neuroblastoma Sarcoma

Interventions allogeneic bone marrow transplantation filgrastim

Updated 6 times since 2017 Last updated: May 12, 2010 Started: Aug 31, 2003 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Kidney Cancer and Leukemia and is currently completed. Fred Hutchinson Cancer Center leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
May 2022 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — May 2022 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fred Hutchinson Cancer Center

Data source: Fred Hutchinson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States
• Seattle, United States